TY - CHAP A1 - Weber, Hans-Joachim A1 - Porschen, W. A1 - Dietzel, F. A1 - [u.a.], ED - Streffer, Christian T1 - In vivo analysis of the influence of combined hyperthermia and gamma irradiation on euoxic and hypoxic tumor cells T2 - Cancer therapy by hyperthermia and radiation : [proceedings of the 2. International Symposium on Cancer Therapy by Hyperthermia and Radiation, Essen, 2.-4.6.1977] Y1 - 1978 SN - 0-8067-1701-7 SN - 3-541-71701-7 SP - 276 EP - 277 PB - Urban and Schwarzenberg CY - Baltimore ; Munich [u.a.] ER - TY - JOUR A1 - Porschen, W. A1 - Gartzen, J. A1 - Gewehr, K. A1 - Mühlensiepen, H. A1 - Weber, Hans-Joachim A1 - [u.a.], T1 - In vivo assay of the radiation sensitivity of hypoxic tumour cells : influence of γ-rays, cyclotron neutrons, misonidazole, hyperthermia and mixed modalities JF - The British journal of cancer / Supplement N2 - Tumour cell death can be evaluated in the living mouse by externally measuring the rate of loss of tumour-bound DNA tracer. By sequentially labelling the tumour-bearing animals with ¹²⁵IUdR and ¹³¹IUdR 50 h apart, the average tumour cells at the time of the second injection are labelled by ¹²⁵IUdR and the euoxic tumour cells are specifically labelled with ¹³¹IUdR. Tumour treatment at this stage of labelling permits the observation of the reaction of euoxic cells and average tumour cells and finally yields data on hypoxic cells and thus on the oxygen enhancement ratio. This information adds to results from tumour control and growth delay. With this technique effects were analysed of 60-Co γ-rays, cyclotron neutrons (E = 6 MeV), misonidazole (500 mg/kg body wt) and hyperthermia (42°C water-bath), or combinations of these. Misonidazole (15 min before irradiation) altered the oxygen enhancement ratio by a factor of 1·5 for γ-rays and of 1·1 for neutrons; when evaluated from tumour-growth delay and TCD-50 misonidazole gave a dose modifying factor of 1·47 for γ-rays and of 1·2-1·3 for neutrons. Based on percentage tumour regression 100 days after treatment, the enhancement ratio from hyperthermia (after irradiation) was 2·75 for γ-rays (at 10 Gray) and 2·2 for neutrons (at 3·2 Gray). For neutrons combined with misonidazole and hyperthermia the ratio was 2·4. These results demonstrate that effects of neutron irradiation may be modified by electron-affinic substances and/or hyperthermia. Y1 - 1978 SN - 0306-9443 N1 - Section 6: Sensitization and Hypoxic Cytotoxicity: Effects of Hyperthermia and High Let IS - 3 SP - 194 EP - 197 PB - Lewis CY - London ER - TY - CHAP A1 - Weber, Hans-Joachim T1 - Applied physics of compressible and incompressible fluids T2 - Critical care nephrology / [Hrsg.:] Claudio Ronco and Rinaldo Bellomo Y1 - 1998 SN - 978-94-010-6306-7 SP - 63 EP - 84 PB - Springer CY - Dordrecht ER - TY - JOUR A1 - Weber, Hans-Joachim A1 - Mo, Xiumei T1 - Electrospinning P(LLA-CL) nanofiber: a tubular scaffold fabrication with circumferential alignment / Xiumei Mo, Hans-Joachim Weber JF - Contributions from 6th Austrian Polymer Meeting : Vienna, Austria, September 15 - 17, 2003 / Symposium ed.: W. H. Binder Y1 - 2004 N1 - Österreichische Polymertage <6, 2003, Wien>. - (Macromolecular symposia ; 217,1) SP - 413 EP - 416 PB - Wiley-VCH CY - Weinheim ER - TY - JOUR A1 - Hekmat, Khosro A1 - Salemink, B. A1 - Lauterbach, Gerhard A1 - Schwinger, R. H. G. A1 - Südkamp, M. A1 - Weber, Hans-Joachim A1 - Mehlhorn, U. T1 - Interference by cellular phones with permanent implanted pacemakers: an update JF - Europace. 6 (2004), H. 4 Y1 - 2004 SP - 363 EP - 369 ER - TY - JOUR A1 - Weber, Hans-Joachim A1 - Bhuju, S. A1 - Chandra, S. A1 - Mo, X. T1 - Fabrication of biodegradable nanofibers for tubular scaffolds in regenerative medicine / Weber, H.-J. ; Bhuju, S. ; Chandra, S. ; Mo, X. JF - Biomedizinische Technik. 49 (2004), H. Erg.-Bd. 2, Teil 2 Y1 - 2004 SP - 1016 EP - 1017 ER - TY - JOUR A1 - Weber, Hans-Joachim A1 - Hekmat, K. A1 - Zimmermann, T. A1 - Kampe, S. T1 - Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial / Hekmat, K. ; Zimmermann, T. ; Kampe, S. ; Kasper, S. M. ; Weber, H. J. ; Geissler, H. J. ; Meh JF - Current Medical Research and Opinion. 20 (2004), H. 1 Y1 - 2004 SN - 0300-7995 SP - 121 EP - 126 ER - TY - JOUR A1 - Kaminsky, Randolph A1 - Simons, Antoine A1 - Gatzweiler, Karl-Heinz A1 - Weber, Hans-Joachim T1 - Flow visualization by means of PIV of an artificial aortic heart valve fixed into a mock aorta JF - Acta Mechanica Slovaka 2-A. 9 (2005) Y1 - 2005 SP - 343 EP - 348 ER - TY - JOUR A1 - Kaminsky, Randolph A1 - Weber, Hans-Joachim A1 - Simons, Antoine A1 - Kallweit, Stephan A1 - Kramm, K. A1 - Verdonck, Pascale T1 - Comparison of the flow downstream two prototypes of a new monoleaflet artificial aortic heart valve by means of PIV visualization JF - Computer methods in biomechanics and biomedical engineering. 8 (2005), H. 4, Suppl. 1 Y1 - 2005 SN - 1476-8259 SP - 159 EP - 160 ER - TY - BOOK A1 - Weber, Hans-Joachim A1 - Kaminsky, Radoslav A1 - Kallweit, Stephan A1 - Simons, Antoine T1 - PIV measurements with high temporal resolution behind artificial heart valves Y1 - 2005 N1 - International Symposium on Particle Image Velocimetry <6, 2005, Pasadena, Calif.> ER -